C-Reactive Protein in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy and Relationship with Ventricular Tachycardia

Background. The relationship between C-reactive protein (CRP) elevation and ventricular tachycardia (VT) in arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is unclear. Methods and Results. In 91 consecutive patients with either ARVD/C with or without VT (cases) or idiopathic right...

Full description

Saved in:
Bibliographic Details
Main Authors: Aimé Bonny, Nicolas Lellouche, Ivo Ditah, Françoise Hidden-Lucet, Martial T. Yitemben, Benjamin Granger, Fabrice Larrazet, Robert Frank, Guy Fontaine
Format: Article
Language:English
Published: Wiley 2010-01-01
Series:Cardiology Research and Practice
Online Access:http://dx.doi.org/10.4061/2010/919783
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548719526936576
author Aimé Bonny
Nicolas Lellouche
Ivo Ditah
Françoise Hidden-Lucet
Martial T. Yitemben
Benjamin Granger
Fabrice Larrazet
Robert Frank
Guy Fontaine
author_facet Aimé Bonny
Nicolas Lellouche
Ivo Ditah
Françoise Hidden-Lucet
Martial T. Yitemben
Benjamin Granger
Fabrice Larrazet
Robert Frank
Guy Fontaine
author_sort Aimé Bonny
collection DOAJ
description Background. The relationship between C-reactive protein (CRP) elevation and ventricular tachycardia (VT) in arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is unclear. Methods and Results. In 91 consecutive patients with either ARVD/C with or without VT (cases) or idiopathic right ventricular outflow tract (RVOT) tachycardia (controls), blood sampling were taken to determine CRP levels. In ARVD/C patients with VT, we analyzed the association between VT occurrences and CRP level. Sixty patients had ARVD/C, and 31 had idiopathic RVOT VT. Patients with ARVD/C had a significant higher level of CRP compared to those with RVOT VT (3.5±4.9 versus 1.1±1.2 mg/l, P=.0004). In ARVD/C group, 77%, (n=46) patients experienced VT. Of these, 37% (n=17) underwent blood testing for CRP within 24 h after the onset of VT and the remaining 63% (n=29) after 24 h of VT reduction. CRP level was similar in ARVD/C patients with or without documented VT (3.6±5.1 mg/l versus 3.1±4.1 mg/l, P=.372). However, in patients with ARVD/C and documented VT, CRP was significantly higher when measured within 24 hours following VT in comparison to that level when measured after 24 h (4.9±6.2 mg/l versus 3.0±4.4 mg/l, P=.049). Conclusion. Inflammatory state is an active process in patients with ARVD/C. Moreover, there is a higher level of CRP in patients soon after ventricular tachycardia, and this probably tends to decrease after the event.
format Article
id doaj-art-fab0df4c0b5848369711b9266222b0c6
institution Kabale University
issn 2090-0597
language English
publishDate 2010-01-01
publisher Wiley
record_format Article
series Cardiology Research and Practice
spelling doaj-art-fab0df4c0b5848369711b9266222b0c62025-02-03T06:13:16ZengWileyCardiology Research and Practice2090-05972010-01-01201010.4061/2010/919783919783C-Reactive Protein in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy and Relationship with Ventricular TachycardiaAimé Bonny0Nicolas Lellouche1Ivo Ditah2Françoise Hidden-Lucet3Martial T. Yitemben4Benjamin Granger5Fabrice Larrazet6Robert Frank7Guy Fontaine8Service de Cardiologie, Hôpital Saint Camille, 2 rue des pères camilliens, 94366 Bry-sur-Marne, FranceHôpital Henri-Mondor, Fédération de Cardiologie, 51, av Mal de Lattre de Tassigny, 94010 Créteil, FranceDepartment of Internal Medicine, Wayne State University, 5475 Woodward Avenue, Detroit, MI 48202, USAUnité de Rythmologie, Hôpital Pitié Salpêtrière, 47-83, Boulevard de l’Hôpital, 75651 Paris, Cedex 13, FranceService de Médecine, Centre Hospitalier Le Cateau, 28, Boulevard Paturle, 59360 Le Cateau- Cambresis, FranceDépartement de Biostatistique, Hôpital Pitié Salpêtrière, 47-83, Boulevard de l’Hôpital, 75651 Paris, Cedex 13, FranceService de Cardiologie, Hôpital Saint Camille, 2 rue des pères camilliens, 94366 Bry-sur-Marne, FranceUnité de Rythmologie, Hôpital Pitié Salpêtrière, 47-83, Boulevard de l’Hôpital, 75651 Paris, Cedex 13, FranceUnité de Rythmologie, Hôpital Pitié Salpêtrière, 47-83, Boulevard de l’Hôpital, 75651 Paris, Cedex 13, FranceBackground. The relationship between C-reactive protein (CRP) elevation and ventricular tachycardia (VT) in arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is unclear. Methods and Results. In 91 consecutive patients with either ARVD/C with or without VT (cases) or idiopathic right ventricular outflow tract (RVOT) tachycardia (controls), blood sampling were taken to determine CRP levels. In ARVD/C patients with VT, we analyzed the association between VT occurrences and CRP level. Sixty patients had ARVD/C, and 31 had idiopathic RVOT VT. Patients with ARVD/C had a significant higher level of CRP compared to those with RVOT VT (3.5±4.9 versus 1.1±1.2 mg/l, P=.0004). In ARVD/C group, 77%, (n=46) patients experienced VT. Of these, 37% (n=17) underwent blood testing for CRP within 24 h after the onset of VT and the remaining 63% (n=29) after 24 h of VT reduction. CRP level was similar in ARVD/C patients with or without documented VT (3.6±5.1 mg/l versus 3.1±4.1 mg/l, P=.372). However, in patients with ARVD/C and documented VT, CRP was significantly higher when measured within 24 hours following VT in comparison to that level when measured after 24 h (4.9±6.2 mg/l versus 3.0±4.4 mg/l, P=.049). Conclusion. Inflammatory state is an active process in patients with ARVD/C. Moreover, there is a higher level of CRP in patients soon after ventricular tachycardia, and this probably tends to decrease after the event.http://dx.doi.org/10.4061/2010/919783
spellingShingle Aimé Bonny
Nicolas Lellouche
Ivo Ditah
Françoise Hidden-Lucet
Martial T. Yitemben
Benjamin Granger
Fabrice Larrazet
Robert Frank
Guy Fontaine
C-Reactive Protein in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy and Relationship with Ventricular Tachycardia
Cardiology Research and Practice
title C-Reactive Protein in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy and Relationship with Ventricular Tachycardia
title_full C-Reactive Protein in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy and Relationship with Ventricular Tachycardia
title_fullStr C-Reactive Protein in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy and Relationship with Ventricular Tachycardia
title_full_unstemmed C-Reactive Protein in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy and Relationship with Ventricular Tachycardia
title_short C-Reactive Protein in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy and Relationship with Ventricular Tachycardia
title_sort c reactive protein in arrhythmogenic right ventricular dysplasia cardiomyopathy and relationship with ventricular tachycardia
url http://dx.doi.org/10.4061/2010/919783
work_keys_str_mv AT aimebonny creactiveproteininarrhythmogenicrightventriculardysplasiacardiomyopathyandrelationshipwithventriculartachycardia
AT nicolaslellouche creactiveproteininarrhythmogenicrightventriculardysplasiacardiomyopathyandrelationshipwithventriculartachycardia
AT ivoditah creactiveproteininarrhythmogenicrightventriculardysplasiacardiomyopathyandrelationshipwithventriculartachycardia
AT francoisehiddenlucet creactiveproteininarrhythmogenicrightventriculardysplasiacardiomyopathyandrelationshipwithventriculartachycardia
AT martialtyitemben creactiveproteininarrhythmogenicrightventriculardysplasiacardiomyopathyandrelationshipwithventriculartachycardia
AT benjamingranger creactiveproteininarrhythmogenicrightventriculardysplasiacardiomyopathyandrelationshipwithventriculartachycardia
AT fabricelarrazet creactiveproteininarrhythmogenicrightventriculardysplasiacardiomyopathyandrelationshipwithventriculartachycardia
AT robertfrank creactiveproteininarrhythmogenicrightventriculardysplasiacardiomyopathyandrelationshipwithventriculartachycardia
AT guyfontaine creactiveproteininarrhythmogenicrightventriculardysplasiacardiomyopathyandrelationshipwithventriculartachycardia